Search results for "xselect"

Learn about the 3D imaging technologies advancing phenotypic screening at HCS Pharma

Watch this on-demand webinar to learn how risk-based approaches can be implemented to improve the control of impurities

First and only FDA-cleared, single-biomarker blood test supporting both rule-in and rule-out assessment of amyloid pathology across primary and specialty care settings

The conference will cover disease modeling, drug repurposing, patient registries, clinical management, and international clinical experience, with the aim of bringing currently fragmented expertise together and agreeing practical research priorities

Innovations aim to support earlier infectious disease detection through sensitive and efficient serology testing

Why automated vacuum control is the key to reducing manual errors and giving laboratory scientists their time back

Expansion supports rapid scale-up and development of foundational AI imaging model, to improve clinical trial design across broader range of chest diseases

Guest editorial by By Allyson Kozak, PhD, MBA, NRCC, senior scientific affairs manager for Mass Spectrometry and Women’s Health at Roche Diagnostics

SPARC 3.0 performs measurements more than twice as fast and calibrates automatically, enabling researchers to carry out larger numbers of measurements under comparable conditions

Uncover why UV-Vis is overtaking ICP-MS as the smarter option for environmental field monitoring

Join experts from OmniAb and Genedata to discover how integrated data workflows, high-throughput screening, and advanced analytics are helping researchers accelerate antibody discovery and identify promising therapeutic candidates with greater confidence

In collaboration with Siemens Healthineers, this advanced PET/CT technology helps expand access to cancer imaging closer to patients

Andelyn is leveraging its AAV Curator Platform to execute a multi-phase program to advance AAV9-GM2 for dosing patients

Dr. Ben Murdock explains how flow cytometry is uncovering immune signatures in amyotrophic lateral sclerosis and how these could help guide new treatment strategies

Inceptua Group selected to manage TikoMed’s Named Patient Program for investigational therapy ILB in amyotrophic lateral sclerosis (ALS)

New Orbitrap Isora workflow integrates mass spectrometry, Vanquish Duo UHPLC System and Isotope Discoverer Software to bring molecular-level isotope ratio analysis to more researchers worldwide